Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s share price gapped up prior to trading on Monday . The stock had previously closed at $21.51, but opened at $22.79. Anbio Biotechnology shares last traded at $23.06, with a volume of 564 shares trading hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, February 9th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Anbio Biotechnology presently has an average rating of “Hold”.
View Our Latest Analysis on NNNN
Anbio Biotechnology Price Performance
Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last announced its earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $2.29 million for the quarter.
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
See Also
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
